Very true and here is a possible extended scenario that some BP could be attempting: think about this and a REAL possibility...
1) Assume no one sent registered letters to SEC / Peregrine / Nasdaq 2) Reverse split twisted to the arms of the BOD and current shareholders reduce their voting power by xx% 3) Next a slew of news comes out from corners unexpected 4) Next the large authorized shares on the shelf get handed out and become Outstanding Shares... 5) Here it comes... More news from unexpecting corners 6) Here it really comes .... A BP deal that includes 1 for 1 shares of this Company where SOMEONE just was handed by twisted arms a NON-split authorized shelf which would have been an added bonus.
Always assume Big Pharma is trying to gain leverage in some way and always do everything possible to maintain retail leverage as much as you can.
Send in those registered letters to Peregrine / the SEC and Nasdaq .... because the game changes quickly and the lid will not remain forever. : )
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!